# US 2020/0346034 A1 · Heart arrhythmia non-invasive treatment device and method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0346034 A1
- Document ID: US20200346034A1
- Status: Published application
- Kind: A1
- Application number: 16/764,967
- Filed: 2018-11-15
- Published: 2020-11-05
- Earliest claimed: 2017-11-16
- Assignees: EBAMed SA
- Applicants: EBAMed SA
- Inventors: Adriano GARONNA; Giovanni LEO
- Web page: https://patentgrep.com/patent/US20200346034A1

## CPC

- A61N 5/1037: {taking into account the movement of the target, e.g. 4D-image based planning}
- A61B 5/0036: {including treatment, e.g., using an implantable medical device, ablating, ventilating}
- A61B 5/113: occurring during breathing
- A61B 5/349: Detecting specific parameters of the electrocardiograph cycle
- A61B 8/0883: {for diagnosis of the heart}
- A61N 5/1049: {for verifying the position of the patient with respect to the radiation beam}
- A61N 5/1068: {Gating the beam as a function of a physiological signal}
- G16H 40/60: for the operation of medical equipment or devices
- A61B 2018/00351: {Heart}
- A61B 2018/00577: {Ablation}
- A61B 2034/2065: {Tracking using image or pattern recognition}
- A61B 2090/3937: {Visible markers}
- A61B 2090/3954: {magnetic, e.g. NMR or MRI}
- A61N 2005/1058: {using ultrasound imaging}
- A61N 2005/1061: {using an x-ray imaging system having a separate imaging source}
- A61N 2005/1087: {Ions; Protons}
- A61N 2005/1097: {Means for immobilizing the patient}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

The present invention relates to a heart tissue ablation device comprising a charged particle emitting system 1, a control system 2 for instructing the accelerator and beamline when to create the beam and what its required properties should be, a patient positioning and verification system, an ultrasound cardiac imaging system 3 performed on the patient, able to track the target movement, a computer program to determine and record the safe motion margins, the treatment plans for one or more motion phases and a computer program to regulate the control system 2 to load the correct irradiation plan according to the motion phase and if the position of the target is inside of the position margin, the irradiation is enabled and if the position of the target is outside of the position margin, the irradiation is disabled.

## Claims

### Claim 1

Heart arrhythmia treatment device comprising:
a charged particle emitting system (1) for creating the charged particle beam to perform the ablation of a given tissue,
a control system (2) for instructing the charged particle emitting system (1) when to create a beam with required properties according to an irradiation plan,
an ultrasound cardiac imaging system (5), able to image a predefined heart region relevant to assess the ablation target motion and the relevant cardiac and respiratory cycle phase,
characterized in that
the control system (2) is controlled so as to load the irradiation plan based on the information of the cardiac and respiratory motion phase.

### Claim 2 (depends on 1)

Heart arrhythmia treatment device according to claim 1, further comprising a patient positioning system (3) which comprises a robotic treatment table (4) and immobilization systems to position the patient.

### Claim 3 (depends on 1, 2)

Heart arrhythmia treatment device according to claims 1 to 2, further comprising a verification system composed of an imaging system based on double X-rays or Cone-beam Computer Tomography to verify the patient positioning.

### Claim 4 (depends on 1, 2, 3)

Heart arrhythmia treatment device according to any one of claims 1 to 3, further comprising a calculation unit to process the ultrasound images of the ultrasound cardiac imaging system:
at a planning stage, to define fiducials of the target volume in the Computer Tomography images to track and
at a treatment stage, to determine the relevant irradiation plan for the identified cardiac and respiratory motion phase,
to quantify the difference in fiducials' position between the acquired ultrasound images and their positions at planning stage.

### Claim 5 (depends on 4)

Heart arrhythmia treatment device according to claim 4, wherein the calculation unit commands the control system (2) such that if the target position is determined to be within the established safety margins according to the relevant treatment plan, enables irradiation of the target and if not, disables irradiation.

### Claim 6 (depends on 1, 2, 3, 4, 5)

Heart arrhythmia treatment device according to claims 1 to 5, wherein the charged particles are chosen from the group comprising protons, carbon, oxygen and helium ions.

### Claim 7 (depends on 6)

Heart arrhythmia treatment device according to claim 6, wherein the charged particles are protons.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

Heart arrhythmia treatment device according to any one of claims 1 to 7, wherein the imaging system (5) comprises at least one ultrasound transducer comprising an optical or magnetic marker coupled with cardiac and/or respiratory motion sensors.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7)

Heart tissue ablation device according to any one of claims 1 to 7, further comprising a cardiac (ECG) and respiratory (abdomen motion via optical sensors or other) cycle monitors working in combination with the ultrasound cardiac imaging system (5).

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

Heart arrhythmia treatment device according to any one of claims 1 to 8, wherein the charged particle emitting system (1) comprises an accelerator and a beamline, adapted to create a beam with a desired intensity, position, angle and energy,

### Claim 11

Heart arrhythmia treatment method comprising:
a motion planning step (S101) establishing an irradiation plan where nominal target positions of the heart tissue to ablate, including motion boundaries for safe irradiation set for each of the planned phases, are defined using 4D-CT and ultrasound imaging for one or more cardiac and respiratory cycle phases,
a patient positioning step (S102) where a patient is positioned in the treatment room via patient immobilization systems and robotic motion systems for the treatment table/chair,
a patient position verification step (S103) where the patient position is verified through embarked in-room Computer Tomography (CT) or double X-ray imaging for position verification and position re-alignment process,
an irradiation step (S104) where a single irradiation is emitted at prescribed angle of prescribed volume of the heart together with non-invasive imaging step via an ultrasound system consisting of one or multiple ultrasound transducers placed out of the irradiation field combined with cardiac and respiratory motion sensors,
a judgment step (S105), where based on the imaging results, the target position is determined in real-time, a relevant motion phase is identified, an established irradiation plan is chosen and if needed, loaded by the control system (2) and the target position is compared to an expected position, and wherein if the target position is outside of pre-established boundaries, the beam irradiation is paused and if the position is within the boundaries, irradiation is allowed, and
in the case of irradiation with multiple angles, when irradiation is completed on one angle, irradiation is stopped and the beam delivery system is moved to a new predetermined angle, and the above steps are repeated.

### Claim 12 (depends on 11)

Heart arrhythmia treatment method according to claim 11, wherein the motion planning step comprises
taking ultrasound and CT images of the heart either simultaneously or one after the other for at least a few points in cardiac and respiratory cycles,
determining the target region in CT images for one or more motion phases,
determining the beam irradiation parameters for each of the chosen motion phases based on the target region and surrounding healthy tissues,
determining, for each of the chosen motion phases, boundaries for the target region outside of which irradiation should be stopped because it is unsafe,
performing an image segmentation on ultrasound images,
co-registering/fusing the ultrasound images with MRI or CT images where the target region appears,
selecting one or more of the automatically segmented and registered reference points/lines in the ultrasound frames based on their stability of relative position with respect to the target regions for adjacent cardiac and respiratory motion phases (so-called fiducials),
Determining the correlation between motion boundaries in the CT image from the treatment plan and the equivalent motion boundaries for the ultrasound fiducials.

### Claim 13 (depends on 12)

Heart arrhythmia treatment method according to claim 12, wherein the judgment step comprises
performing image co-registration on ultrasound images during irradiation,
determining the position of the fiducials on the ultrasound images by segmentation,
determining the corresponding target motion phase based on the position of the fiducials and possibly, respiratory and cardiac cycle information,
sending the information about the relevant motion phase and irradiation plan to the control system (2) (if the irradiation plan is different from the presently loaded one, the new relevant irradiation plan is loaded),
comparing the determined positions to the nominal positions for safe irradiation for that particular irradiation plan,
in case the difference in position is smaller than the pre-established margin, sending a gating signal to the control system (2) to allow irradiation, or
in case the difference in position is larger than the pre-established margin, sending a gating signal to the control system (2) to stop the irradiation.
